These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4897659)

  • 1. Integrated EEG. variability: drug effects in acute schizophrenics.
    Marjerrison G; Keogh RP
    Can Psychiatr Assoc J; 1969 Aug; 14(4):403-5. PubMed ID: 4897659
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of chlorprothixene and haloperidol in acute schizophrenia.
    Marjerrison G; Bowman R; Keogh RP
    Can Psychiatr Assoc J; 1971 Dec; 16(6):533-6. PubMed ID: 4947173
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
    Serafetinides EA; Willis D; Clark ML
    J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
    Ban TA
    Curr Ther Res Clin Exp; 1969 May; 11(5):284-8. PubMed ID: 4977400
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
    Fux M; Belmaker RH
    Isr J Psychiatry Relat Sci; 1991; 28(1):37-40. PubMed ID: 1830565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 9. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
    Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 13. Haloperidol--new addition to the drug treatment of schizophrenia.
    Stewart A; Lafave HG; Segovia G
    Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
    [No Abstract]   [Full Text] [Related]  

  • 14. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 16. High dosage haloperidol in chronic schizophrenia.
    McCreadie RG; MacDonald IM
    Br J Psychiatry; 1977 Sep; 131():310-6. PubMed ID: 334315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.
    Shopsin B; Gershon S; Thompson H; Collins P
    Arch Gen Psychiatry; 1975 Jan; 32(1):34-42. PubMed ID: 1089401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled evaluation of haloperidol, chlorpromazine, and sodium amobarbital: intramuscular short-term use in acute psychotic patients.
    Shopsin B; Hekimian LJ; Gershon S; Floyd A
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):561-73. PubMed ID: 4980886
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive indices for chlorpromazine therapy in schizophrenics.
    Dixon PA; Oforah E; Makanjuola R
    Br J Clin Pharmacol; 1982 Aug; 14(2):273-7. PubMed ID: 7104178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.